MedPath
FDA Approval

Hydrocodone Bitartrate and Homatropine Methylbromide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 30, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydrocodone(5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Novel Laboratories, Inc.

793518643

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novel Laboratories, Inc.

Lupin Pharmaceuticals,Inc.

Novel Laboratories, Inc.

793518643

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocodone Bitartrate and Homatropine Methylbromide

Product Details

NDC Product Code
43386-118
Application Number
ANDA091528
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 30, 2024
Code: NO70W886KKClass: ACTIBQuantity: 5 mg in 1 1
Code: 68JRS2HC1CClass: ACTIBQuantity: 1.5 mg in 1 1
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath